Unum Therapeutics
Why Robinhood?
You can watch UMRX and buy or sell other stocks, ETFs, and their options commission-free!About UMRX
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17.
UMRX Key Statistics
Stock Snapshot
The current Unum Therapeutics(UMRX) stock price is $9.40, with a market capitalization of 1.61B. The stock trades at a price-to-earnings (P/E) ratio of -12.95.
On 2026-05-25, Unum Therapeutics(UMRX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.68M.
Over the past 52 weeks, Unum Therapeutics(UMRX) stock has traded between a high of $43.73 and a low of $4.80.
Over the past 52 weeks, Unum Therapeutics(UMRX) stock has traded between a high of $43.73 and a low of $4.80.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.